鹿得医疗(920278)披露2025年年度业绩快报,2月27日股价下跌1.25%
Sou Hu Cai Jing·2026-02-27 15:53

Core Viewpoint - The company reported a decline in both revenue and net profit for the fiscal year 2025, indicating potential challenges in its financial performance and market position [1]. Financial Performance - Total revenue for the reporting period was 300,328,058.66 yuan, a year-on-year decrease of 12.85% [1]. - Net profit attributable to shareholders was 18,913,373.29 yuan, down 31.33% compared to the previous year [1]. - Net profit after deducting non-recurring gains and losses was 16,662,834.86 yuan, reflecting a 36.42% decline year-on-year [1]. - Basic earnings per share were 0.11 yuan, which is a 31.33% decrease from the prior year [1]. Asset and Equity Position - Total assets at the end of the reporting period amounted to 589,226,940.16 yuan, showing a year-on-year growth of 11.27% [1]. - Shareholder equity attributable to the company was 383,776,435.86 yuan, which represents a 4.00% decline compared to the previous year [1]. Stock Performance - As of the market close on February 27, 2026, the stock price was 9.51 yuan, down 1.25% from the previous trading day [1]. - The stock opened at 9.63 yuan, reached a high of 9.65 yuan, and a low of 9.47 yuan during the trading session [1]. - The trading volume for the day was 16,028,800 yuan, with a turnover rate of 2.27% [1].

HONSUN-鹿得医疗(920278)披露2025年年度业绩快报,2月27日股价下跌1.25% - Reportify